M&G Investment Management Limited 13D and 13G filings for Barinthus Biotherapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 10:17 am Unchanged |
2024-02-13 | 13G | Barinthus Biotherapeutics plc BRNS |
M&G Investment Management Limited | 5,197,349 13.480% |
0 (Unchanged) |
Filing |
| 2023-01-20 1:35 pm Unchanged |
2023-01-20 | 13G | Barinthus Biotherapeutics plc BRNS |
M&G Investment Management Limited | 5,197,349 13.940% |
0 (Unchanged) |
Filing |
| 2023-01-20 09:19 am Purchase |
2023-01-20 | 13G | Barinthus Biotherapeutics plc BRNS |
M&G Investment Management Limited | 5,197,349 13.940% |
5,197,349 (New Position) |
Filing |
| 2022-10-07 4:36 pm Purchase |
2022-10-07 | 13G | Barinthus Biotherapeutics plc BRNS |
M&G Investment Management Limited | 5,197,349 13.970% |
5,197,349 (New Position) |
Filing |